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Abstract 
Background: Declining malaria prevalence and pressure on external funding have increased the need for efficiency 
in malaria control in sub‑Saharan Africa (SSA). Modelled Plasmodium falciparum parasite rate (PfPR) maps are increas‑
ingly becoming available and provide information on the epidemiological situation of countries. However, how these 
maps are understood or used for national malaria planning is rarely explored. In this study, the practices and percep‑
tions of national decision‑makers on the utility of malaria risk maps, showing prevalence of parasitaemia or incidence 
of illness, was investigated.
Methods: A document review of recent National Malaria Strategic Plans was combined with 64 in‑depth interviews 
with stakeholders in Kenya, Malawi and the Democratic Republic of Congo (DRC). The document review focused on 
the type of epidemiological maps included and their use in prioritising and targeting interventions. Interviews (14 
Kenya, 17 Malawi, 27 DRC, 6 global level) explored drivers of stakeholder perceptions of the utility, value and limita‑
tions of malaria risk maps.
Results: Three different types of maps were used to show malaria epidemiological strata: malaria prevalence using 
a PfPR modelled map (Kenya); malaria incidence using routine health system data (Malawi); and malaria prevalence 
using data from the most recent Demographic and Health Survey (DRC). In Kenya the map was used to target pre‑
ventative interventions, including long‑lasting insecticide‑treated nets (LLINs) and intermittent preventive treatment 
in pregnancy (IPTp), whilst in Malawi and DRC the maps were used to target in‑door residual spraying (IRS) and LLINs 
distributions in schools. Maps were also used for operational planning, supply quantification, financial justification and 
advocacy. Findings from the interviews suggested that decision‑makers lacked trust in the modelled PfPR maps when 
based on only a few empirical data points (Malawi and DRC).
Conclusions: Maps were generally used to identify areas with high prevalence in order to implement specific inter‑
ventions. Despite the availability of national level modelled PfPR maps in all three countries, they were only used in 
one country. Perceived utility of malaria risk maps was associated with the epidemiological structure of the country 
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Background
Declining malaria prevalence [1–3] and malaria mortal-
ity [4], pressure on external funding and renewed inter-
est in malaria elimination [5, 6] have highlighted the need 
for increased efficiency of malaria control in sub-Saharan 
Africa (SSA) [7–9]. The Global Technical Strategy for 
Malaria 2016–2030 calls for a more evidence-driven allo-
cation of resources and tailored approach to malaria con-
trol [5, 10].
In the last 10–15  years, maps showing the propor-
tion of individuals infected at a given point in time are 
increasingly replacing or becoming available alongside 
qualitative, eco-climatic risk and routine data maps 
across a number of countries in SSA [11]. Modelled PfPR 
maps are developed by assembling community-based 
malaria parasite prevalence (PfPR) data from the general 
population or specific population surveys, such as school 
based children [12–16], and used within geostatistical 
models to provide estimates of infection prevalence at 
unsampled locations [17]. In contexts lacking complete, 
good quality routine health data, modelled PfPR maps 
provide an indication of the epidemiological characteris-
tics of malaria transmission sub-nationally. In their appli-
cation to national malaria control, the assumption is that 
these estimates of sub-national malaria risk can be used 
to prioritize and target interventions leading to a more 
appropriate allocation of resources and more efficient 
prevention and response [8].
Maps have long been used as evidence by national 
stakeholders to inform policy priorities, strategies and 
interventions [3, 18], they represent one form of relevant 
evidence for health decision-making. More broadly, the 
literature explores the use of evidence in health plan-
ning and indicates there are multiple conceptualizations 
around evidence and use of evidence [19, 20]. Some arti-
cles focus on scientific evidence as derived from ran-
domized clinical trials [21, 22], while others refer to a 
more general definition of evidence which includes infor-
mation and data [23]. Literature on the quality and use 
of routine health data, surveillance data and survey data 
at national and district levels in low and middle-income 
countries (LMIC) is expanding [23–27], as is the use of 
health information in humanitarian settings [28]. Studies 
looking specifically at the use of spatially defined health 
data and maps to plan interventions are less common. 
There remains a need to understand how evidentiary 
tools like malaria risk maps, showing prevalence of para-
sitaemia or incidence of illness, are understood and uti-
lized in practice by policy makers and implementers. 
This study considered the use of spatially aggregated or 
mapped data as a form of evidence for decision-making 
on malaria interventions and strategies, and explored the 
use of malaria risk maps as defined by malaria policy-
makers and key stakeholders.
This study was part of the evaluation of the Informa-
tion for malaria (INFORM) and LINK-Data for malaria 
decision-making (LINK) projects, which supported 14 
malaria endemic countries in SSA to develop preva-
lence modelled risk maps and epidemiological profiles 
of malaria. The aim of this study was to explore the 
practises and perceptions of National Malaria Control 
Programmes (NMCPs) staff and other malaria control 
stakeholders on the use of malaria risk maps, in prioriti-
zation and targeting of interventions.
Methods
Study site and context
The study was conducted between April 2017 and June 
2018 in Kenya, Malawi and the Democratic Republic of 
Congo (DRC). The study sites were limited to the cit-
ies where national level stakeholders are based (Nairobi, 
Lilongwe, Blantyre and Kinshasa). Interviews with global 
stakeholders were conducted in Nairobi, Dakar (during 
the Multilateral Initiative on Malaria) or remotely.
Malaria is endemic across the three countries with 
a predominance of Plasmodium falciparum infection. 
According to the World Health Organization (WHO) 
guidelines, all three countries are in the malaria con-
trol phase [29]. Malaria epidemiology, decision-making 
structures and policies for control in each country are 
presented in Tables 1 and 2.
Study design
This study was embedded within the internal evaluation 
of the LINK-Data for malaria decision-making project 
with the aim to assess the contribution of the INFORM 
and LINK epidemiological profiles, data and maps to 
malaria decision-making in SSA. The analytical frame-
work for the evaluation was adapted from the Research 
Impact Framework of Kuruvilla et al. [30] and provided 
the basis for the analysis of how malaria data were used 
for decision-making.
and use was driven by perceived need, understanding (quality and relevance), ownership and trust in the data used 
to develop the maps.
Keywords: Risk maps, Modelled PfPR maps, Targeting, National Malaria Control Programme, Kenya, Malawi, 
Democratic Republic of Congo
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This study was a narrative synthesis of the findings from 
a document review of national malaria strategic plans 
(NMSPs), and in-depth interviews (IDIs) with national 
level malaria control decision-makers and stakeholders. 
The document review sought evidence of the use of risk 
maps in national malaria strategic plans. The review was 
supplemented with IDIs and aimed to elucidate prac-
tises and perceptions of stakeholders on the utility of risk 
maps in their decision-making, in particular, how these 
maps affect prioritization and targeting of interventions, 
along with the reasoning behind their decisions.
Prioritization and targeting are often difficult to disen-
tangle and in fact in practice, one inevitably implies the 
other, but in general prioritization refers to the type of 
intervention or the type of delivery method that should 
be selected for a given geographical area [31]; where as 
targeting is about which geographical areas and/or sub-
populations should the intervention and delivery method 
be deployed in [32–34].
Document review
The latest NMSPs were reviewed for each of the three 
countries to identify the type of malaria risk maps 
included (e.g. eco-climatic, based on malaria cases rou-
tine data, or based on parasite prevalence surveys) in 
the strategies and the reason why the maps were used. 
Reasons for the use of maps were extracted from each 
document and analysed by examining the content of text 
referring to the maps across the entire document.
Stakeholder interviews
IDIs were conducted with 64 stakeholders purposively 
selected across the three countries and among experts at 
global level: Kenya 14, Malawi 17, DRC 27, global stake-
holders 6 (Table 3). Stakeholders interviewed were from 
the NMCPs, Ministry of health (MoH) at national level, 
statistical and pharmaceutical governmental bodies, 
United Nation agencies (UN), donors, Non-Governmen-
tal Organizations (NGOs), and researchers. Stakeholder 
designation within these categories are not presented by 
country, to maintain anonymity, but for NMCP designa-
tions included director, vector control, monitoring, eval-
uation and surveillance, research, case management, and 
malaria in pregnancy (MiP) units; for MoH Health Infor-
mation System and policies units; for government bodies 
statistical office and national pharmacies; UN agencies 
included WHO and UNICEF; donors included the Presi-
dent’s Malaria Initiative (PMI), Global Fund (GF) and the 
UK Department for International Development  (DFID); 
NGOs were both national and international and 
researchers included epidemiologists and entomologists.
Interviews were conducted using theme guides to 
explore the following: malaria data produced, data acces-
sibility, data use, perception of the quality of malaria data 
available, type of maps produced and used, type of maps 
and purpose of use, use for prioritization and targeting, 
collaboration among the stakeholders, and examples of 
decisions driven by data and epidemiological maps.
Stakeholders were invited to an interview at a time and 
place of their convenience. Interviews were conducted by 
LG in collaboration with national co-investigators (GO, 
LNM, CMC, FM) in English or French, according to the 
official language and were audio-recorded where consent 
was provided. Detailed field notes were taken where con-
sent to record the interview was declined.
Data management and analysis
Interviews were transcribed, translated into English and 
imported into NVivo software (QSR international) Ver-
sion 11 for coding and analysis. The transcripts were 
coded according to four levels of analysis: (1) type of 
maps: data used in existing maps; (2) use of maps: by 
stakeholders, at which level, for what purpose, non-use 
of maps; (3) value and perception of maps: usefulness of 
the data, trust in the data, the value of the maps; (4) sug-
gestions for and criticisms of the maps: production, dis-
semination and future development of maps. Additional 
themes and sub-themes that emerged from the data were 
Table 2 National Malaria Control Programme (NMCP) role and structure
Role The programme, under the responsibility of the Ministry of Health, defines and leads the strategy of prevention and control of 
malaria at the national level. The NMCP is responsible for ensuring compliance with the malaria prevention and treatment 
national guidelines
National structure Despite slight variations, the NMCPs are generally composed of a number of divisions including: case management; vector 
control; epidemiology and surveillance; monitoring and evaluation; research; finance, procurement and supply. The NMCP 
collaborates with partners, at national and international levels, through formal technical working groups (TWGs) and infor‑
mal structures, and supports and supervises the implementation of malaria control interventions at national and district (or 
sub‑county) level. Malaria policies are generally defined at national level
Sub‑national structure At district (or sub‑county) level, a malaria officer from the NMCP is often in charge of the support and supervision of malaria 
control activities at all levels of health facilities, and at the community level for the delivery of interventions including long‑
lasting insecticidal nets (LLINs) distributions, indoor residual spraying (IRS), intermittent preventive treatment in pregnancy 
(IPTp) and case management
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added to the coding framework inductively and further 
explored using content analysis.
During data analysis, all stakeholders were assigned 
an anonymous code. Quotes were identified using labels 
including: role (NMCP, MoH, researcher, partner), 
country (Kenya, Malawi, DRC, global) and a consecu-
tive number. Findings were validated by stakeholders 
(NMCP representatives and researchers) during a three-
day workshop in September 2018. The main findings of 
the study were presented, discussed and validated with 
national co-investigators on day 1, and with NMCP rep-
resentatives on day 2. Adjustments were made based on 
feedback from workshop participants, and on day 3 the 
findings were presented to an open audience, including 
international malaria experts.
Results
The use of malaria risk maps in the National Malaria 
Strategic Plans (NMSPs) is presented and the percep-
tions of stakeholders about the utiliy and limitation of the 
maps are explored in further depth.
Risk maps included in the National Malaria Strategic Plans
In all three NMSPs, malaria risk maps showing the dis-
tribution of infection and, consequently, the risk of being 
infected were included. However, each country used a dif-
ferent type of malaria risk map, based on different kinds 
of data: a modelled PfPR map in Kenya, an incidence map 
based on routine data in Malawi and a prevalence map 
based on the Demographic Health Survey (DHS) data in 
DRC (Fig.  1). Although the three maps were developed 
using different methods and types of data, they were used 
in the NMSPs for the same purpose, that of showing epi-
demiological strata and identifying high risk areas where 
interventions would be implemented.
In the Kenya NMSP 2019–2023 [35] a panel of four 
maps were included to show and describe the malaria 
prevalence levels and changes over time (same map 
updated by different year- 2000, 2005, 2010, 2015). Kenya 
presented seven strata of the PfPR in 2 to 10 year old chil-
dren: malaria free, < 1%, 1% to 5%, 5% to 10%, 10% to 20%, 
20 to 40%, > 40%. The strategy indicated that each vector 
control intervention (LLINs distribution, larval source 
control and IRS) would be deployed in specific areas 
according to the stratification [35].
The Malawian NMSP 2017–2022 [36] includes a panel 
of four maps from 2011 to 2015 to illustrate the evolution 
of risk according to the Annual Parasite Incidence and 
the number of cases per 1000 population by each district 
(divided into 5 categories: under 150, 150–250, 250–350, 
350–450, over 450). According to the strategy, interven-
tions would be allocated universally, with the exception 
of IRS, which would be implemented in high burden dis-
tricts or areas [36].
The Congolese NMSP 2016–2020 [37] included one 
map that showed the stratification of the PfPR in < 5 years 
old children in four strata: pre-elimination in North 
Kivu (PfPR < 5%), control/consolidation (PfPR 6–30%), 
control/intensification (PfPR > 30%) and urban malaria 
(in Kinshasa). The strategy stated that all interventions 
would be allocated universally, with the exception of IRS, 
which would be implemented in urban and pre-elimina-
tion areas, and LLINs distribution in schools in the tropi-
cal areas [37].
Perceptions of the stakeholders—what drives the use 
of malaria risk maps
The analysis of stakeholder interviews focused on two 
main thematic areas: types of use of risk maps—includ-
ing strategies, prioritization, targeting and operational 
planning, and the drivers of the use of risk maps—includ-
ing perception of value and limitations of the maps by 
malaria stakeholders.
Use of risk maps
The information derived from the interviews matched 
and enriched that from the NMSPs. Risk maps were 
primarily used for strategic planning, in particular to 
aid in the selection of geographic areas or population 
sub-groups for delivery of an intervention (targeting); 
however, operational planning and advocacy were also 
identified as important uses.
Prioritization and targeting
Selection of interventions and geographic areas.
Intervention choices were based on evidence from 
efficacy and effectiveness studies, as well as WHO 
Global Malaria Programme (GMP) guidelines. Across 
the three countries, treatment was widely prioritized 
over prevention as it was perceived as a tool for ‘sav-
ing lives’ as opposed to preventing infection. Stake-
holders, including NMCPs and donors, reported that 
interventions were prioritized based on their perceived 
efficacy, which primarily meant ensuring the avail-
ability of commodities. Anti-malarials and diagnostics 
Table 3 Participants by role and country
Kenya Malawi DRC Global
NMCP, MoH and other 
government officers
4 5 9 /
Partners officers (UN 
agencies, donors, 
NGOs officers)
8 8 16 5
Researchers 2 4 2 1
Total 14 17 27 6
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Fig. 1 Malaria risk maps utilized in the most recent NMSPs in Malawi (a), Kenya (b), and DRC (c) 
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for case management were the first priority, followed 
by LLINs and IPTp for prevention. This prioritization 
was also seen in the Global Fund proposals reviewed 
in each country, where the majority of the requested 
budget was for commodities: artemisinin-based combi-
nation therapies (ACTs), rapid diagnostic tests (RDTs) 
and LLINs [38, 39]. This was confirmed in conversa-
tions with the NMCP officers who oversee Global Fund 
grants interviewed.
“You have to make sure that lifesaving interventions 
are taken care of fully… there was no question… 
there was no debate about that. There have to be 
diagnostics, there have to be medicines. That’s num-
ber one, because we have to save people from dying. 
Then the second thing was prevention, accessibility 
to nets.” (NMCP officer 1, Kenya)
“Of course commodities [for case management] 
comes first. Next is the nets.” (NMCP officer 6, 
Malawi).
The consideration of the geographical areas where 
interventions would be implemented was based on maps. 
Targeting was applied to all preventative interventions 
(LLINs, IPTp, IRS) in the case of Kenya; while limited to 
IRS, or LLINs in schools, or IPTp at the community level 
in the case of Malawi and DRC. In Kenya, the delivery of 
LLINs and IPTp was only implemented in the 16 endemic 
counties of the Lake and Coast regions (out of 47 coun-
ties in total) and IRS was implemented in two counties 
(Homa Bay and Migori). In DRC and Malawi, LLINs and 
IPTp were delivered in the entire country through using 
a universal coverage approach, however maps were uti-
lized to identify high burden areas where additional 
interventions or delivery sites were appropriate, such as 
LLINs distributed in schools and the delivery of IPTp at 
the community level in DRC (Table 4) and IRS in Malawi. 
Specifically, IRS in Malawi was scaled up from one to 
seven highly endemic districts in 2012, while in DRC, 
IRS was implemented by mining companies in the areas 
where they were operating.
Participants in Malawi and DRC perceived targeting to 
be associated with limited resources, while in Kenya par-
ticipants felt the use of a targeted approach was primar-
ily to increase efficiency and value for money in malaria 
control.
In DRC, with severe resource constraints, the NMCP 
used what they called ‘time prioritization’, as defined by a 
report developed by the African Leaders Malaria Alliance 
(ALMA) [40]. This refers to the practice of implement-
ing malaria control interventions in high burden regions 
initially, whilst searching for funding to implement the 
interventions in additional geographical areas. As inter-
national partners explained:
“[in] DRC: what they have done is a time-bound 
prioritization, so they covered their 2018 and 2019 
LLINs campaigns and 2020 has gaps. This it is 
essentially an operational programmatic prioritiza-
tion of your limited resources… This is just common 
sense decisions a government has to make” (Partner 
2, Global).
In Malawi, although LLINs and IPTp were universally 
implemented, targeting was perceived, by some, as a bet-
ter strategy given the resource contraints and geographi-
cal variations in risk, as explained by one official:
“We should stop actually doing the blanket inter-
ventions because it is a waste of resources in some 
areas where they don’t need those interventions so 
we need more data that can guide us to plan for tar-
geted interventions because in Malawi we have… 
yes we have malaria but… all areas are not affected 
equally.” (NMCP officer 6, Malawi)
However, some other stakeholders in DRC and Malawi 
perceived the prioritization and targeting of high impact 
interventions (LLINs and IPTp) not suitable in a coun-
try where the risk of malaria is high almost everywhere. 
They felt that universal coverage of LLINs and IPTp was 
the most appropriate strategy at this stage, weakening the 
need for PfPR risk maps
“When you are a country where everywhere is highly 
endemic then there is not much space anyway for 
prioritization.” (Partner 2, global)
Also reflected in statements by participants from DRC 
and Malawi:
“There is no prioritization of provinces [region] in 
relation to prevalence…not at the moment.” (Partner 
14, DRC)
“If we had universal coverage in terms of the vector 
control, that would be much better so that at least 
we reduce the incidence, after reducing the incidence 
then you can now try to see where can we go….[tar-
geting].” (Partner 14, Malawi).
Using maps for planning of operational interventions, 
commodity quantification and advocacy
Malaria maps were used for purposes beyond strategic 
planning and targeting. These included project monitor-
ing or planning, supply quantification, financial justifica-
tion, and budget advocacy purposes.
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Guiding and justifying commodity quantification 
and operational interventions
NMCPs case management division and NGOs officers 
described the use of risk maps to guide the quantifica-
tion of commodities, such as RDTs and ACT, according 
to the level of burden. Indeed, population at risk, number 
of malaria cases and deaths and malaria prevalence maps 
were utilized conjointly to quantify malaria commodities 
in a specific area.
“[high endemicity areas] these areas are supplied 
differently than the others. For example in Haut-
Uele where the endemicity is very high with seasonal 
upsurges, even we talked about the epidemics, the 
attention is different, we bring in the inputs we repo-
sitioned elsewhere.” (Partner officer 19, DRC).
Maps were also used to justify national decisions, 
such as where LLINs needed to be allocated, to the sub-
regional government. Malaria control interventions, such 
as universal LLIN distribution and IRS, are highly visible 
and often local governments are interested in implement-
ing the intervention in their area, independent of the 
level of malaria risk. Having a malaria risk map helped 
the central government to justify the geographical alloca-
tion of interventions to the sub-national level.
“Accepting like when your program tells you really 
we are not giving you nets, not because we don’t like 
your county or your county didn’t vote for govern-
ment, no. It’s because the evidence … do not have 
the high prevalence in malaria in your county you 
don’t need this. And there’re now starting to actually 
understand this… because I think one of the ques-
tion was why are you not spraying my county, why 
are you not giving me nets. You are there sitting in 
a national meeting and hearing that nets have been 
distributed why not my county. So having a docu-
ment or having something that you can show them 
and tell them it’s because of one, two, three.” (Partner 
officer 8, Kenya).
Monitoring interventions and trends over time
Maps were specifically used for annual reviews and dur-
ing the mid-term and final reviews of the NMSP. Malaria 
risk maps of consecutive years were key to showing pro-
gress and readjusting the strategy over time, as Kenyan 
officials explained:
“For us at the national level we’re using that [the 
map] to show progress of malaria control over time.” 
(NMCP officer 1, Kenya)
“We’re able to see the map actually shrinking or is it 
becoming darker but I can report that actually we’re 
heading [in] the right direction it’s becoming lighter 
and lighter. …. Yeah we’ve made a lot of gains since 
2010. 2007 MIS, 2010 [MIS], 2015 [MIS] we are see-
ing progress.”(NMCP officer 14, Kenya).
Resource mobilization and advocacy
The visual nature of the maps was seen to encourage their 
use as powerful tools for resource mobilization and advo-
cacy, and training purposes. Respondents in Kenya and 
Malawi gave examples where maps were used to encour-
age donors or other stakeholders to provide interventions 
to specific areas where there were gaps.
“If any donor comes, wants to come with any inter-
ventions, we direct him to say okay, according to 
the… the distribution of the burden of malaria I 
think you go to this location.” (NMCP officer 15, 
Malawi).
Maps were used to advocate for funds at the sub-
national level, in countries with some degree of devolu-
tion, and by community-based organizations to advocate 
for funds or for social accountability.
“They have used that [maps]…..to advocate for the 
funds from the county.” (NMCP officer 1, Kenya)
“In 2013 they allocated 113 million shillings for 
malaria [in Nairobi]. So now we were questioning 
what did you do with this money? Which interven-
tions did you do?” (Partner officer 11, Kenya).
Finally, the ease with which malaria risk could be visu-
alized was highly appreciated and often used for training 
purposes to catch attention of the audience.
“When I am training them on malaria epidemiol-
ogy and decision making I project for them and give 
them soft copy of my presentation. In this county 
these are the areas that you should focus your efforts 
more.” (Researcher 4, Kenya).
Factors driving the use of risk maps by decision‑makers
The second key theme explored in the analysis were the 
factors driving the use of risk maps for strategic planning. 
The decision to use malaria risk maps was motivated by 
their availability (or potential to be developed), the tech-
nical characteristics of the maps, and the alignment of 
the maps with stakeholder expectations. Technical char-
acteristics of the maps included: the nature and quality 
of the data from which the maps were developed and the 
granularity of the data; while the alignment of the maps 
with stakeholder expectations included a range of related 
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factors such as: alignment with the expected malaria 
epidemiological situation in the country (based on eco-
climatic zone, routine data, or indications from sentinel 
sites); knowledge, trust and perceived ownership of the 
data and of the process of developing the maps.
Timely availability of maps and data for their development
Malaria risk maps were developed using either multiple 
PfPR data points, DHS prevalence data at one point in 
time, or by using routine health information system data. 
Modelled PfPR maps were available in all three countries 
at the time of development of the most recent NMSP, 
provided by the INFORM and LINK projects. In Kenya 
modelled PfPR maps were developed around the time 
of the mid-term NMSP review and were incorporated 
in the revised strategy 2015–2019; in DRC the maps 
were developed in 2014 and the NMSP 2016–2020 was 
developed in 2015–2016; in Malawi modelled PfPR maps 
were developed in 2014 and the new strategy 2017–2022 
in 2016–2017. Timely alignment of data and maps with 
malaria strategic planning cycles was a key element that 
increased their utilization. NMSPs are developed by 
NMCPs and technical partners every 5–10 years and are 
revised as interim strategies every couples of years. The 
fact that the maps were developed with recent data, at the 
time of the NMSP revision, facilitated their utilization.
Routine health data were available in each country and 
by sub-national level. These data were perceived by some 
stakeholders as advantageous due to their being more 
recent and timely compared to national survey data, 
which are produced every 3 to 5 years. Timeliness of the 
monthly routine data (the period needed to send data 
from health facilities to the central level) was perceived 
as an issue by some policy makers.
Technical characteristics and quality of the data and maps
A key concern raised about the use of maps for deci-
sion-making involved the nature, representativeness 
and perceived quality of the data from which the maps 
were developed. Stakeholders in Malawi and DRC raised 
concerns about a lack of transparency and clarity on the 
source and breadth of data in the models used to develop 
the maps. This meant that stakeholders felt that they 
were not able to judge the quality of data from which the 
map was developed.
“It is the data that was included in the model that 
was my biggest problem …You need to choose, 
which is the data that you need…” (NMCP officer 3, 
Malawi)
“I think that there are surely some biases that have 
entered through different studies that have been 
taken into account.” (NMCP officer 1, DRC).
“Because as long as we don’t have good data, the 
maps will not work. The maps will not work at all.” 
(NMCP officer 3, Malawi).
Conversely, routine health data were perceived as 
understandable and useful in indicating the distribu-
tion of malaria burden and guiding decisions despite the 
acknowledgement that the data was not always of good 
quality. Perceptions of the quality of routine data varied 
across countries and stakeholders.
“We can go with the health zone routine data… as 
much as we can. I think that at least the routine 
data allows… to have a distribution variation from 
one area to another and the routine data still pro-
vide satisfactory information on the fact that such 
area is less affected than another. Okay, we know 
that in terms of accuracy, it is not very reliable but 
in terms of distribution of burdens, it is quite satis-
factory. If we have surveys with satisfactory accuracy 
up to the next province, we work on the improve-
ment of the routine for the provincial deployment. 
This is the compromise that seems reasonable to me 
for a gigantic country like the DRC.” (NMCP officer 
1, DRC)
“We still have challenges with the routine data, we 
have challenges with the completeness, accuracy and 
timeliness.” (NMCP officer 6, Malawi)
Concerns were raised about the granularity of the data 
and some participants questioned how representative 
the maps were of populations at the sub-national level. 
In Kenya, modelled PfPR maps for the county level were 
available and appreciated. Modelled PfPR maps with dis-
trict-level resolution were available in DRC and Malawi. 
However, in Malawi some stakeholders either did not 
know of their existence or did not feel that the data used 
to develop the map was accurate enough to be represent-
ative at the district level.
“Prevalence alone I think we don’t have enough 
[prevalence] data to come at district levels.” (NMCP 
officer 15, Malawi).
DRC officers reportedly felt that the PfPR data available 
were not sufficient to develop a representative map and 
as such they decided to use the most recent DHS data 
(2013–2014), despite it only providing provincial-level 
resolution, however, they have pushed to make the 2020 
DHS/MIS survey representative of the 26 provinces.
“I’ll be more comfortable with surveys at 26 prov-
inces, at least they give me an image close to the 
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reality …..models ….give me things that deviate from 
the realities.” (NMCP officer 1, DRC).
The fact that DHS and MIS data were representative at 
national or at the higher sub-national levels (e.g. region 
or province) but not at district-level was perceived as a 
limitation of the national survey data. As one respondent 
explained:
“Unfortunately, MIS [Malaria Indicator Survey] 
only gives us by region, it’s not by district. So the 
smallest you can go with analysis is by region. That’s 
one of the challenges it will have.”(Partner officer 14, 
Malawi)
NMCP officers and other stakeholders in Malawi 
reported using incidence data from the routine health 
information system because they perceived this to be the 
only way to develop a map at district level that they felt 
they could trust.
Stakeholder ownership, involvement and alignment 
with stakeholders expectations
In Kenya, the NMCP and other stakeholders interviewed 
were proud to have shifted to a targeted approach for 
malaria interventions and appreciated the modelled PfPR 
maps. Respondents felt a sense of ownership because 
their suggestions of what data was useful were included 
in the maps.
Stakeholders in all three countries highlighted the 
importance of the sense of ownership of the maps by 
NMCP and of engagement of researchers and technical 
advisors in supporting the NMCP to develop risk maps. 
Kenyan NMCP officers mentioned the long term (over 
20 years) and daily collaboration with KEMRI- Wellcome 
Trust; how the researchers have consistently contributed 
to the TWGs by reviewing interventions, routine data, 
discussing changes in strategy and policy and generating 
and sharing new national and global evidence. By con-
trast, in the DRC and Malawi, despite the involvement 
of the Malaria Alert Centre (College of Medicine) in 
Malawi, there was a keen sense from the interviews that 
the NMCP did not feel sufficiently involved in research 
generally, and specifically in the development of the PfPR 
maps. More importantly, the lack of involvement of the 
NMCP in the development of the PfPR maps had nega-
tive implications for the use of the evidence based on the 
maps.
As one NGO official in Malawi explained:
“Sometimes if you don’t involve the national pro-
gram at the beginning …there is unwillingness to 
accept whatever comes out of your study.” (Partner 
officer 17, Malawi).
However, in addition to trust in the data and legitimacy 
of the process, there were also indications that the choice 
of map used in the NMSP and other national documents 
could be influenced by whether what the maps showed 
was in alignment with what decision-makers expected 
to see based on other data sources or publications. In 
DRC, for example, the expectations of the NMCP, based 
on the routine data, aligned better with a map that was 
produced using DHS data than with the modelled map. A 
local officer commented:
“The rendering of this model did not satisfy us, 
because it did not add to what we expected, and 
what we aimed at in terms of return routine field 
data… so finally we chose to make our stratifica-
tion on the basis of the parasitic prevalence of EDS 
[DHS].” (NMCP officer 1, DRC).
In Malawi, participants expressed a lack of confidence 
in the modelled PfPR maps as they did not show the pro-
gress that was perceived to have been achieved by stake-
holders based on a Roll Back Malaria (RBM) publication 
[41]. In that study, a multivariate analysis and the Lives 
Saved Tool (LiST) were used to hypothesize that malaria 
interventions from 2000 to 2010 had reduced mortality 
in children in the country, (mortality was assumed to be 
largely caused by malaria), which contradicted the mod-
elled PfPR maps, as explained by a researcher:
“[the PfPR map] showed that there were no changes 
in in malaria prevalence in the country from 2000 
to 2010…in contrast with the RBM impact series 
[which] showed that Malawi got a decrease preva-
lence and actually… Malawi was also awarded by 
the ALMA [African Leaders Malaria Alliance] with 
a prize.” (Researcher 1, Malawi).
The data and the indicators utilized by the two studies 
were different and not comparable. However, it is logi-
cal given alternative versions of achievement that NMCP 
would be less accepting of the one suggesting no change 
in malaria prevalence after their scale-up of interven-
tions. Furthermore, the interpretation of conflicting data 
could also be a challenge. Stakeholders in both countries 
mentioned that they preferred maps that showed what 
they expected to see, a decreased number of cases in 
Malawi and alignment with routine data in DRC.
Discussion
In this study the use and perception of malaria risk maps 
were investigated in three low-medium to high-burden 
African countries. Previous studies have reviewed the use 
of cartography in malaria control planning [11, 42]; high-
lighted the crucial role played by additional data available 
and new techniques of modelling to tailor sub-national 
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intervention plans [43, 44]; and described initiatives 
to support the use of modelled maps of malaria risk by 
malaria policy-makers [45]. This study explored both the 
ways in which the maps were used and the reasons why 
they were used by local officials and key stakeholders for 
strategic planning in the study settings.
This study found the use of maps to be broader than 
for strategic planning and targeting including for project 
monitoring or planning, supply quantification, financial 
justification, and budget advocacy. The study also found 
perceived needs, understanding and trust of the data 
source and process to construct the maps to be impor-
tant drivers of the type of map chosen and their use.
Drivers of use of malaria risk maps: trust and ownership 
in the “input” data
A variety of malaria risk maps were used for strategic 
planning and targeting to different extents across the 
three countries. Drivers of the use of malaria risk maps 
for strategic planning were: perceived need for risk maps; 
an understanding of what data was used to develop the 
map, including its limitations; and trust and ownership 
in the data and how it was used in the maps (Fig.  2). 
Perceived needs determined the preferred type of map. 
While the understanding of the source of data and pro-
cess through which the maps were generated led to trust 
and ownership of the maps and ultimately to their use for 
strategic planning.
Perceived needs
Perceived needs of malaria risk maps depended mainly 
on the perception of the level of heterogeneity of malaria 
in the country. For instance, malaria decision-makers 
interviewed in this study all recognized that Kenya had a 
heterogeneous distribution of the risk. Malawi and DRC 
had homogeneous distributions of malaria risk; however, 
homogeneity was perceived differently by the stakehold-
ers according to their interests and roles. For example, 
in Malawi, transmission was perceived by some to dif-
fer at the sub-national level (from urban to rural and 
around the lake areas), whereas others described it as 
homogenous; in DRC the majority pointed out the high 
homogeneity, but others highlighted pockets of very high 
or very low prevalence (Kivu) or urban areas, where it 
would potentially be useful to develop alternative con-
trol interventions. Therefore, some stakeholders did not 
perceive any need for risk maps, while others expressed 
a need for highly granular maps defining malaria risk at 
the sub-district level. The potential to create maps that 
identify sub-national pockets of high risk of malaria is 
dependent upon the quality of the routine data avail-
able, prevalence data will not allow this identification. 
The desire for granular and timely maps along with the 
Understand
Trust & 
Ownership
Perceived need
Percepons of 
heterogeneity of malaria 
transmission
Clarity/transparency of data & 
processes of map construcon
Able to make informed 
judgement on the map 
quality and relevance 
Involvement in data generaon 
design and/or map producon
Use map for strategic 
planning
Timely availability of granular 
geo-located data 
Alignment with other sources of 
informaon and stakeholders' 
expectaons
Global policies and 
requirements from donors
Percepons of the need of 
opmizing resources 
Support from the research 
community 
FACTORS OUTPUTS OUTCOMES
Fig. 2 Factors influencing the type and use of malaria risk maps by malaria stakeholders
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increasing availability and quality of malaria routine data 
drove some countries towards the use of routine data in 
the stratification of malaria, either using Test Positivity 
Rate or case incidence [46, 47].
The lack of perceived need for malaria risk maps 
by some stakeholders in countries with homogenous 
malaria transmission is understandable, as high impact 
interventions are and will be implemented universally for 
a significant period of time. Universal coverage among 
populations at greater risk is the main objective for coun-
tries such as DRC and Malawi. However, strengthening 
surveillance and use of data was perceived as important 
when allocating limited resources and to monitor pro-
gress of the control interventions..
The perception that resource allocation needed to be 
optimized because of limited availability, such as in DRC, 
or to increase the value for money of the interventions, 
such as in Kenya, also increased the need for targeting 
and developing risk maps. Finally, global policies, such 
as the Global Technical Strategy for malaria 2016–2030, 
requirements from donors, the Global Fund in particu-
lar, and the increasing support in the field for the genera-
tion and use of data (for instance through USAID funded 
project of Measure evaluation) would have influenced 
the perceived needs for production (and possibly use) 
malaria risk maps or stratification.
Understanding
Understanding the meaning of malaria risk maps 
depended on the ability of decision-makers to make an 
informed judgment on the map quality and relevance. 
In turn, this depended on the transparency of data and 
how the maps were developed, and on the availability of 
timely and geolocated data at the desired level of granu-
larity. The availability of timely, good quality, highly gran-
ular data would help to construct clearer maps and allow 
stakeholders to appreciate the quality of the map and 
understand what they are showing. However, high quality 
and timely data at high granular resolution are often not 
available [23] and policy makers therefore need to make 
decisions based on the maps using the data available or 
on modelled data.
Across the three countries malaria survey data and 
routine data were available (although to different extents 
and quality). Malaria surveys were generally well under-
stood and trusted, however they were not available at 
the desired level of resolution and in the required time-
line. Routine data were understood, although not always 
trusted. However, although most of the stakeholders 
were aware of the limitations in quality, they also con-
sidered them as the only data able “to give an idea” of 
the malaria risk at district level. The need to adjust for 
reporting rates, missing data from private sector, and 
the proportion of malaria that was confirmed versus 
suspected was recognized. But, whilst hoping that these 
issues would be resolved over time, policymakers were 
comfortable using maps based on this data because they 
understood the limitations and were able to make their 
recommendations based on this knowledge. Knowledge 
and understanding of the source of data and their limi-
tations, together with knowledge and understanding of 
the processes of map construction were key factors in the 
decision-making by policy makers on what maps were 
appropriate to use.
Trust and ownership
Stakeholders preferred to develop maps using data and 
processes that were owned, understood and trusted by 
the country. As noted in previous studies [22, 46, 48], the 
alignment with other sources of information and stake-
holder expectations were considered important for stake-
holders to have trust in the maps.
The NMCP in Kenya perceived the need of moving to 
a targeted approach to interventions, had a significant 
amount of data available to develop sub-national maps, 
understood and trusted the results of the modelled maps, 
and was reported by stakeholders as having allocated a 
budget for subsequent development of maps. Conversely, 
the NMCP in Malawi did not trust the results of the PfPR 
modelling, because the modelled maps contradicted a 
Roll Back Malaria report, and preferred instead to use 
routine incidence data to develop a map at district level. 
The NMCP in DRC were aware of the limited number of 
survey points available to develop a map representative 
at district level and therefore they did not trust modelled 
maps derived from these data points. They also did not 
trust the quality of their routine data and chose to use the 
most recent DHS survey data to develop a map.
Different levels of engagement and support from the 
research community are likely to have influenced the 
development and use of a specific type of malaria risk 
map. The strong and long-term collaboration between 
the KEMRI-Wellcome Trust in Nairobi and the Kenya 
NMCP likely supported the perceived need to move to 
a targeted approach. This collaboration ensured NMCP 
involvement in the collection of data and definition of the 
type of maps to be developed, and consequently facili-
tated understanding of the data and the process used 
to develop the map. The long-term participation of the 
KEMRI- researchers in TWGs, and the alignment of the 
production of the maps with the NMSP cycle, facilitated 
the understanding of the process of generating modelled 
maps. In Malawi, the Malaria Alert Centre- College of 
Medicine, a nationally recognized long-term partner was 
involved in the development of the modelled map and 
profile; however, this element was not sufficient. The lack 
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of alignment of the map with the expected results pre-
vented the modelled map from being used.
Policy implications
Malaria risk maps were produced and used for malaria 
decision-making, such as strategic planning, targeting, 
quantification, monitoring and advocacy. The Global 
Malaria Strategy 2016–2030 and the High Burden High 
Impact initiative highlighted the importance of increas-
ing targeted approaches to malaria control, even in coun-
tries with a high prevalence, in order to meet the 2030 
targets. However, tailored interventions may be appro-
priate in countries with heterogeneous risk, such as in 
many Sahelian countries in West Africa and the east and 
Horn of Africa, including Kenya. Conversely countries 
like Malawi and the DRC, where the risk is still very high 
almost everywhere, are facing multiple challenges. First, 
the need to ensure universal coverage must be balanced 
with the need to have an accurate picture of the sub-
national level to identify pocket areas where a combina-
tion of additional and innovative interventions (such as 
vaccination, chemoprophylaxis in infant, or additional 
nets in school age children) may be appropriate. Sec-
ond, due to limited resources there is a need to prior-
itize malaria control in particular areas or using specific 
interventions.
Modelled malaria risk maps could be one tool used to 
support malaria decision-making across countries. It is, 
therefore, important to continue supporting the devel-
opment of high quality data from surveys and routine 
health systems that can be used to develop malaria risk 
maps and guide and monitor interventions. Moreover, 
it is key to develop maps using data and methods that 
policy makers understand, trust and own. The political 
dimension of the choice and use of data by policy makers 
should be recognized [49], as Newman said “while supply 
of research information is important, it will only be used 
to inform policy if it is accessed, valued and understood by 
policymakers” [50].
Limitations
The paper analysed and compared decision-maker’s per-
ceptions of the usefulness of malaria maps across just 
three countries in SSA. The three countries have different 
malaria epidemiological profiles (quasi homogenous in 
Malawi and DRC and heterogeneous in Kenya) impacting 
on the perceived need for PfPR maps to stratify malaria 
control interventions. Perceptions of the utility of these 
maps may have differed in countries with varied geo-
graphical and epidemiological contexts.
Not all of the stakeholders who were identified and 
contacted were available for interview. It is possible 
that those interviewed were more interested in malaria 
epidemiology and risk maps or in talking with research-
ers and therefore held different views to those who did 
not participate. All interviews were conducted by two 
researchers, one international and one national. It is pos-
sible that the presence of the international interviewer 
could have affected the way the participants replied to the 
questions. The interviewers were perceived as colleagues 
by researchers and officers of international organizations, 
while government officers perceived them as external fig-
ures. However, the fact that one interviewer was external 
to the country could have allowed the respondents to 
speak more freely about their perceptions.
Conclusions
Maps were generally used to target areas of high malaria 
risk with specific interventions. Although national level 
modelled PfPR maps were available in all three countries, 
they were not used in two of the countries. Perceived 
utility of malaria risks maps was associated with the epi-
demiological structure of the country and use was driven 
by perceived need, understanding (quality and relevance), 
ownership and trust in the data. Evidence and informa-
tion to guide interventions, including malaria risk maps 
trusted and understood by the policy makers, are key in 
supporting national stakeholders to achieve their goal of 
effective malaria control.
Abbreviations
ALMA: African Leaders Malaria Alliance; ANC: Ante‑natal care; DFID: United 
Kingdom Department for International Development; DHS: Demographic 
health survey; DRC: Democratic Republic of Congo; GF: Global Fund; IDI: 
In‑depth interview; INFORM: Information for Malaria Project; IPTp: Intermit‑
tent preventive treatment for pregnant women; IRS: Indoor residual spraying; 
ITN: Insecticide‑treated net; KEMRI: Kenya Medical Research Institute; LINK: 
LINK‑Data for malaria decision‑making project; LiST: Lives saved tool; LLINSs: 
Long lasting insecticide treated nets; LMIC: Low and middle‑income countries; 
MiP: Malaria in pregnancy; MoH: Ministry of Health; NGO: Non‑governmental 
organizations; NMCP: National Malaria Control Programme; NMSP: National 
Malaria Strategic Plan; PfPR: Plasmodium falciparum parasite rate; PMI: Presi‑
dent’s Malaria Initiative; RBM: Roll Back Malaria; SSA: Sub‑Saharan Africa; TWGs: 
Technical working groups; UN: United Nation agencies; USAID: United States 
Agency for International Development; WHO: World Health Organization.
Acknowledgements
We gratefully acknowledge the help of all 64 NMCPs staff, national and 
international malaria stakeholders who accepted to be interviewed in the 
framework of this project.
Authors’ contributions
LG conducted the interviews in collaboration with national co‑investigators 
(GO, LNM, CMC, FM) and drafted the manuscript. JW designed and supervised 
the empirical study and guided the writing of the manuscript. JH, JiL and YS 
coded the data. JH, JP, JL, RWS and CAL contributed to the conceptualization 
and analysis of the study. All authors read and approved the final manuscript.
Funding
Support for this work was provided by the UK’s Department for International 
Development for their continued support to a project Strengthening the Use of 
Data for Malaria Decision Making in Africa (DFID Programme Code 203155).
Page 16 of 17Ghilardi et al. Malar J          (2020) 19:353 
RWS is funded by Wellcome Trust Principal Fellowship (Numbers 103602 & 
212176) and acknowledges the support of the Wellcome Trust to the Kenya 
Major Overseas Programme (Numbers 092654 & 203077).
 Availability of data and materials
The datasets used and/or analysed during the current study are available from 
the corresponding author on reasonable request.
Ethics approval and consent to participate
Ethics approvals were obtained from the Scientific and Ethics Boards of Kenya, 
Malawi, DRC and the Ethics Committee of the London School of Hygiene and 
Tropical Medicine. (Kenya Medical Research Institute No.: KEMRI/RES/7/3/1; 
Malawi College of Medicine Research and Ethic Committee No.: P.08/17/2230; 
Ecole de Santé Publique de Kinshasa No.: ESP/CE/041/2017; London School 
of Hygiene and Tropical Medicine Ethics Committee No.: 11834).Stakeholders 
were informed of the aim of the study using an information and consent form. 
Participants gave written informed consent prior to the interview including 
permission for the use of anonymous quotes.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1 Department of Disease Control, London School of Hygiene and Tropical 
Medicine, London, UK. 2 Kinshasa School of Public Health, University of Kin‑
shasa, Mont Amba/Lemba, BP 11850 Kin I, Kinshasa, Democratic Republic 
of Congo. 3 Department of Infectious Disease Epidemiology, London School 
of Hygiene and Tropical Medicine, London, UK. 4 London School of Econom‑
ics and Political Science, Houghton Street, London WC2A 2AE, UK. 5 Kenya 
Medical Research Institute‑Wellcome Trust Research Programme, P.O. 
Box 43640‑00100, Nairobi, Kenya. 6 Centre for Tropical Medicine and Global 
Health, Nuffield Department of Clinical Medicine, University of Oxford, OX3 
7LJ Oxford, UK. 7 World Vision UK, 1rb, 11 Belgrave Rd, Pimlico, London SW1V 
1RB, UK. 8 Mwanza Intervention Trials Unit (MITU)/ National Institute for Medi‑
cal Research (NIMR)‑ Mwanza Research Centre, P.O BOX 11936, Isamilo road, 
Mwanza, Tanzania. 9 Department of Health Systems and Policy, College 
of Medicine, University of Malawi, Blantyre, Malawi. 
Received: 28 May 2020   Accepted: 23 September 2020
References
 1. Weiss DJ, Lucas TCD, Nguyen M, Nandi AK, Bisanzio D, Battle KE, et al. 
Mapping the global prevalence, incidence, and mortality of Plasmodium 
falciparum, 2000–17: a spatial and temporal modelling study. Lancet. 
2019;394:322–31.
 2. World Health Organization. World malaria report 2019. Geneva: World 
Health Organization; 2019.
 3. Snow RW, Sartorius B, Kyalo D, Maina J, Amratia P, Mundia CW, et al. The 
prevalence of Plasmodium falciparum in sub‑Saharan Africa since 1900. 
Nature. 2017;550:515–8.
 4. Gething PW, Casey DC, Weiss DJ, Bisanzio D, Bhatt S, Cameron E, et al. 
Mapping Plasmodium falciparum mortality in Africa between 1990 and 
2015. N Engl J Med. 2016;375:2435–45.
 5. World Health Organization. 2016–2030 global malaria programme. 
Geneva: World Health Organization; 2016.
 6. Feachem RGA, Chen I, Akbari O, Bertozzi‑Villa A, Bhatt S, Binka F, et al. 
Malaria eradication within a generation: ambitious, achievable, and 
necessary. Lancet. 2019;394:1056–112.
 7. Walker PGT, Griffin JT, Ferguson NM, Ghani AC. Estimating the most 
efficient allocation of interventions to achieve reductions in Plasmodium 
falciparum malaria burden and transmission in Africa: a modelling study. 
Lancet Glob Health. 2016;4:e474–84.
 8. Scott N, Hussain SA, Martin‑Hughes R, Fowkes FJI, Kerr CC, Pearson R, et al. 
Maximizing the impact of malaria funding through allocative efficiency: 
using the right interventions in the right locations. Malar J. 2017;16:368.
 9. Clements ACA, Reid HL, Kelly GC, Hay SI. Further shrinking the malaria 
map: How can geospatial science help to achieve malaria elimination? 
Lancet Infect Dis. 2013;13:709–18.
 10. WHO, RBM partnership to end malaria. High burden to high impact: a 
targeted malaria response. Geneva, World Health Organization. 2018.
 11. Omumbo JA, Noor AM, Fall IS, Snow RW. How well are malaria maps used 
to design and finance malaria control in Africa? PLoS ONE. 2013;8:e53198.
 12. Gitonga CW, Karanja PN, Kihara J, Mwanje M, et al. Implementing school 
malaria surveys in Kenya: towards a national surveillance system. Malar J. 
2010;9:306.
 13. Swana EK, Yav TI, Ngwej LM, Mupemba BN, Suprianto, Mukeng CK, et al. 
School‑based malaria prevalence: informative systematic surveillance 
measure to assess epidemiological impact of malaria control interven‑
tions in the Democratic Republic of the Congo. Malar J. 2018;17:141.
 14. Okebe J, Affara M, Correa S, Muhammad AK, Nwakanma D, Drakeley 
C, et al. School‑based countrywide seroprevalence survey reveals 
spatial heterogeneity in malaria transmission in the Gambia. PLoS ONE. 
2014;9:e110926.
 15. Houngbedji CA, Chammartin F, Yapi RB, Hürlimann E, N’Dri PB, Silué KD, 
et al. Spatial mapping and prediction of Plasmodium falciparum infec‑
tion risk among school‑aged children in Côte d’Ivoire. Parasit Vectors. 
2016;9:494.
 16. Chacky F, Runge M, Rumisha SF, MacHafuko P, Chaki P, Massaga JJ, et al. 
Nationwide school malaria parasitaemia survey in public primary schools, 
the United Republic of Tanzania. Malar J. 2018;17:452.
 17. Diggle PJ, Giorgi E. Model‑based geostatistics for prevalence mapping in 
low‑resource settings. J Am Stat Assoc. 2016;111:1096–120.
 18. Snow RW, Noor AM. Malaria risk mapping in Africa: The historical context 
to the Information for Malaria (INFORM) project. Working Paper in sup‑
port of the INFORM Project funded by the Department for International 
Development and the Wellcome Trust, Nairobi, Kenya, 2015.
 19. Nutley S, Walter I, Davies HTO. Promoting evidence‑based practice: 
models and mechanisms from cross‑sector review. Res Soc Work Pract. 
2009;19:552–9.
 20. Leir S, Parkhurst JO. Evidence‑based policymaking: an important first 
step and the need to take the next. In: The politics of evidence: from 
evidence‑based policy to the good governance of evidence; Parkhurst J, 
Ed. Taylor & Francis Group, 2017.
 21. Tesfazghi K, Hill J, Jones C, Ranson H, Worrall E. National malaria vector 
control policy: an analysis of the decision to scale‑up larviciding in Nige‑
ria. Health Policy Plan. 2016;31:91–101.
 22. D’Souza BJ, Parkhurst JO. When “Good Evidence” is not enough: a case of 
global malaria policy development. Glob Challenges. 2018;2:1700077.
 23. Wickremasinghe D, Hashmi IE, Schellenberg J, Avan BI. District decision‑
making for health in low‑income settings: a systematic literature review. 
Health Policy Plan. 2016;31:ii12–24.
 24. Bhattacharyya S, Berhanu D, Taddesse N, Srivastava A, Wickremasinghe D, 
Schellenberg J, et al. District decision‑making for health in low‑income 
settings: a case study of the potential of public and private sector data in 
India and Ethiopia. Health Policy Plan. 2016;31:ii25–34.
 25. Hanson K, Schellenberg J. Commentary‑District decision‑making to 
strengthen maternal, newborn and child health services in low‑income 
settings. Health Policy Plan. 2016;31:ii1–2.
 26. Avan BI, Berhanu D, Umar N, Wickremasinghe D, Schellenberg J. District 
decision‑making for health in low‑income settings: a feasibility study of 
a data‑informed platform for health in India, Nigeria and Ethiopia. Health 
Policy Plan. 2016;31:ii3–11.
 27. Gautham M, Spicer N, Subharwal M, Gupta S, Srivastava A, Bhattacharyya 
S, et al. District decision‑making for health in low‑income settings: a 
qualitative study in Uttar Pradesh, India, on engaging the private health 
sector in sharing health‑related data. Health Policy Plan. 2016;31:ii35–46.
 28. Checchi F, Warsame A, Treacy‑Wong V, Polonsky J, van Ommeren M, 
Prudhon C. Public health information in crisis‑affected populations: 
a review of methods and their use for advocacy and action. Lancet. 
2017;390:2297–313.
 29. WHO. Global malaria programme. A framework for malaria elimination. 
Geneva: World Health Organization; 2017.
 30. Kuruvilla S, Mays N, Walt G. Describing the impact of health services and 
policy research. J Health Serv Res Policy. 2007;12(1_suppl):23–31.
 31. Winskill P, Walker PG, Cibulskis RE, Ghani AC. Prioritizing the scale‑up of 
interventions for malaria control and elimination. Malar J. 2019;18:122.
Page 17 of 17Ghilardi et al. Malar J          (2020) 19:353  
•
 
fast, convenient online submission
 •
  
thorough peer review by experienced researchers in your field
• 
 
rapid publication on acceptance
• 
 
support for research data, including large and complex data types
•
  
gold Open Access which fosters wider collaboration and increased citations 
 
maximum visibility for your research: over 100M website views per year •
  At BMC, research is always in progress.
Learn more biomedcentral.com/submissions
Ready to submit your research ?  Choose BMC and benefit from: 
 32. Chitnis N, Schapira A, Schindler C, Penny MA, Smith TA. Mathemati‑
cal analysis to prioritise strategies for malaria elimination. J Theor Biol. 
2018;455:118–30.
 33. Stresman G, Bousema T, Cook J. Malaria hotspots: is there epidemiological 
evidence for fine‑scale spatial targeting of interventions? Trends Parasitol. 
2019;35:822–34.
 34. Bousema T, Stresman G, Baidjoe AY, Bradley J, Knight P, Stone W, et al. 
The impact of hotspot‑targeted interventions on malaria transmission 
in Rachuonyo South District in the Western Kenyan Highlands: a cluster‑
randomized controlled trial. PLoS Med. 2016;13:e1001993.
 35. MoH. Kenya. National Malaria Strategy 2019‑2023. Nairobi, 2019.
 36. Governement of Malawi, Ministry of Health. Malawi Malaria Strategic Plan 
2017–2022. Lilongwe 2017.
 37. Programme nationale de lutte contre le paludisme (PNLP). Plan strate‑
gique national de lutte contre le paludisme. Kinshasa, 2016;81.
 38. The Global Fund, Standard Concept Note, Investing for impact against 
HIV, tuberculosis and malaria. Malawi. 2014.
 39. The Global Fund, Re‑programming request, MoH, Kenya, Malaria compo‑
nent. 2015.
 40. African Leaders Malaria Alliance. How countries prioritized malaria control 
interventions: A review of recipients’ decisions under the Global Fund’s 
New Funding Model, 2014–2017. Geneva, 2016.
 41. Malawi Malaria Impact Evaluation Group. Evaluation of the Impact of 
Malaria Control Interventions on all cause mortality in children under five 
years on age in Malawi. USAID. 2016;54:5058–61.
 42. Dalrymple U, Mappin B, Gething PW. Malaria mapping: understand‑
ing the global endemicity of falciparum and vivax malaria. BMC Med. 
2015;13:140.
 43. Cohen JM, Le Menach A, Pothin E, Eisele TP, Gething PW, Eckhoff PA, et al. 
Mapping multiple components of malaria risk for improved targeting of 
elimination interventions. Malar J. 2017;16:459.
 44. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IRF, Johnston GL, et al. 
A new world malaria map: Plasmodium falciparum endemicity in 2010. 
Malar J. 2011;10:378.
 45. Howes RE, Hawa K, Andriamamonjy VF, Franchard T, Miarimbola R, Mio‑
ramalala SA, et al. A stakeholder workshop about modelled maps of key 
malaria indicator survey indicators in Madagascar. Malar J. 2019;18:90.
 46. Thawer SG, Chacky F, Runge M, Reaves E, Mandike R, Lazaro S, et al. Sub‑
national stratification of malaria risk in mainland Tanzania: a simplified 
assembly of survey and routine data. Malar J. 2020;19:177.
 47. Alegana VA, Okiro EA, Snow RW. Routine data for malaria morbidity 
estimation in Africa: challenges and prospects. BMC Med. 2020;18:121.
 48. Runge M, Molteni F, Mandike R, Snow RW, Lengeler C, Mohamed A, et al. 
Applied mathematical modelling to inform national malaria policies, 
strategies and operations in Tanzania. Malar J. 2020;19:101.
 49. Paul C, Kramer R, Lesser A, Mutero C, Miranda ML, Dickinson K. Identify‑
ing barriers in the malaria control policymaking process in East Africa: 
insights from stakeholders and a structured literature review. BMC Public 
Health. 2015;15:862.
 50. Newman K, Fisher C, Shaxson L. Stimulating demand for research evi‑
dence: What role for capacity‑building? IDS Bull. 2012;43:17–24.
 51. Macharia PM, Giorgi E, Noor AM, Waqo E, Kiptui R, Okiro EA, et al. Spatio‑
temporal analysis of Plasmodium falciparum prevalence to understand 
the past and chart the future of malaria control in Kenya. Malar J. 
2018;17:340.
 52. Ministry of Health Kenya. The epidemiology and control profile of malaria 
in Kenya: reviewing the evidence to guide the future vector control. 
Nairobi, 2016.
 53. Noor AM, Gething PW, Alegana VA, Patil AP, Hay SI, Muchiri E, et al. The 
risks of malaria infection in Kenya in 2009. BMC Infect Dis. 2009;9:180.
 54. Give Chipeta M, Giorgi E, Mategula D, Macharia PM, Ligomba C, Muny‑
enyembe A, et al. Open Peer Review Geostatistical analysis of Malawi’s 
changing malaria transmission from 2010 to 2017. Wellcome Open Res. 
2019;4:57.
 55. Taylor SM, Messina JP, Hand CC, Juliano JJ, Muwonga J, Tshefu AK, et al. 
Molecular malaria epidemiology: mapping and burden estimates for the 
democratic Republic of the Congo, 2007. PLoS ONE. 2011;6:e16420.
 56. Programme Nationale de Lutte contre le Paludisme (PNLP) An epidemio‑
logical profile of malaria in the Democratic Republic of Congo, 2014.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub‑
lished maps and institutional affiliations.
